Giovanna C. Salata - Publications

Multifunctional nanoparticles for co-delivery of elacridar and paclitaxel for breast cancer local treatment.

Journal: International journal of pharmaceutics

Published: July 21, 2026

Histoprotective and antiproliferative effects of Raloxifene treatment during prostate carcinogenesis in rats.

Journal: Toxicology and applied pharmacology

Published: May 31, 2026

Molecular and Antiangiogenic Effects of Paclitaxel-Loaded Nanoparticles: Influence of the Nanocarrier Type.

Journal: Molecular pharmaceutics

Published: March 06, 2026

Co-delivery of fenretinide and perillyl alcohol for breast cancer pharmacological prevention through nanostructured lipid carriers: characterization, cellular studies and in vivo localization.

Journal: International journal of pharmaceutics

Published: January 16, 2026

Molecular effects of paclitaxel-elacridar nanoemulsions in breast cancer cells: impact on uptake, cell cycle and signaling pathways.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: May 15, 2025

Topical delivery of seriniquinone for treatment of skin cancer and fungal infections is enabled by a liquid crystalline lamellar phase.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: May 30, 2023

Monoolein-based nanodispersions for cutaneous co-delivery of methylene blue and metformin: Thermal and structural characterization and effects on the cutaneous barrier, skin penetration and cytotoxicity.

Journal: International journal of pharmaceutics

Published: September 19, 2022

Phosphatidylcholine-Based Nanoemulsions for Paclitaxel and a P-Glycoprotein Inhibitor Delivery and Breast Cancer Intraductal Treatment.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 27, 2022

A Lipid-Based In Situ-Forming Hexagonal Phase for Prolonged Retention and Drug Release in the Breast Tissue.

Journal: AAPS PharmSciTech

Published: June 13, 2022

Hyaluronic acid nanoemulsions improve piplartine cytotoxicity in 2D and 3D breast cancer models and reduce tumor development after intraductal administration.

Journal: International journal of biological macromolecules

Published: March 31, 2022

Rethinking Breast Cancer Chemoprevention: Technological Advantages and Enhanced Performance of a Nanoethosomal-Based Hydrogel for Topical Administration of Fenretinide.

Journal: AAPS PharmSciTech

Published: February 03, 2022

Microemulsion for Prolonged Release of Fenretinide in the Mammary Tissue and Prevention of Breast Cancer Development.

Journal: Molecular pharmaceutics

Published: September 06, 2021